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We aimed at comparing the positive and negative predictive
values (PPV, NPV) of several intrarenal velocimetric indices
for revealing the presence of renal artery stenosis (RAS)
among hypertensive patients who underwent a renal
angiography for the clinical suspicion of renovascular
hypertension. In 106 patients (200 kidneys), the pulsatility
index (PI) and resistive index (RI), the acceleration time (AT),
and the mean systolic acceleration (ACCsys) were evaluated.
In addition, the maximal systolic acceleration (ACCmax), that
is, the maximal slope of the acceleration phase, and the
maximal acceleration index (AImax), that is, the ratio between
ACCmax and the relative peak systolic velocity, were
calculated. On angiography, we found that 56 (28%) of the
200 arteries had a greater than 60% RAS. PI and RI had an
NPV below 75%, whereas AT, ACCsys, ACCmax, and AImax had
an NPV always above 95%. However, ACCmax, and AImax, at
their best cutoff limits, had higher PPV than ACCsys and AT
(60 and 70% vs 45 and 51%, respectively). Thus, in a cohort of
patients with a high prevalence of RAS, PI and RI failed to
reach an NPV adequate for a screening test. In contrast, all
the acceleration indices we tested had a sufficiently high NPV
but AImax appears superior to the others because of higher
PPV. We propose the evaluation of AImax as an additional
screening test in patients with hypertension and the clinical
suspicion of RAS.
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In recent years, it became increasingly appreciated that renal
artery stenosis (RAS), apart from being responsible for the
elevation of blood pressure in some patients, can cause a
chronic ischemic nephropathy with a progressive loss of renal
function that eventually leads to end-stage renal disease.1,2
Moreover, percutaneous transluminal renal angioplasty alone
or in combination with stent implantation has progressively
emerged as a reliable method for treating both renovascular
hypertension and ischemic nephropathy even in those
patients, like the elderly, in whom the conventional surgical
treatment is not feasible because of the exceedingly high risk.3
Not surprisingly, there has been increasing interest in
developing screening tests capable of accurately detecting
the presence of RAS and also of evaluating its functional
consequences in order to select patients who may actually
benefit from dilation procedures.4
In this respect, already in the early 1990s, the duplex-
Doppler ultrasound examination of the renal artery has
attracted attention because, apart from being non-invasive,
repeatable, and of relatively low cost, it combines the ability
of visualizing the RAS with that of determining the
alterations in renal blood flow through the measurement of
the velocimetric indices.5,6 Yet, the initial enthusiasm toward
this technique has been tempered by the technical difficulties
encountered in measuring the so-called ‘proximal’ veloci-
metric indices, that is, those sampled just at the site of the
arterial narrowing. Although specific, this approach has low
sensitivity, is highly operator and technical equipment
dependent and is afflicted by a high drop-out rate of
unsuccessful investigation because of obesity, abdominal gas,
or unlucky scan window, limitations that led, in earlier
studies, to a low accuracy in detecting significant RAS.7,8
However, more recent investigations, one of which was
performed with contrast enhancement, yielded significantly
better results.9,10
An alternative approach substantially devoid of technical
drop-out has been that of performing the sampling of blood
flow velocity at the renal hilum or in the intraparenchymal
arteries with the so-called ‘distal’ indices. These latter
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measurements, including the pulsatility and resistance indices
(PI and RI), the mean systolic acceleration (ACCsys), and
acceleration time (AT), have the advantage of circumventing
some of the problems related to the proximal ones, in that
being easily sampled distally to RAS allow the evaluation of
damping in kinetic flow energy and pulse wave transfer at any
level of the arterial trunk.11
PI and RI had been extensively applied at first,12–14 but a
comparative study of ours15 indicated that ACCsys and AT
may be superior to PI and RI in detecting a significant RAS.
In another study,16 the combination of PI and AT has been
shown to further improve the diagnostic accuracy of echo-
Doppler investigation. Along this line, Radermacher et al.17
have shown that in main renal arteries in which the proximal
indices could not be determined, the evaluation of AT made
the detection of RAS always possible. As a result, the
approaches at the extrarenal and intrarenal vasculature may
be seen as complementary rather than as an alternative.18
Yet, a potential source of bias even in the measurement of
ACCsys and AT is represented by the shape of the Doppler
spectra, which, even when sampled from a normal artery, are
far from being uniform.19 Herein, we examined the
possibility of circumventing this bias by focusing on the
evaluation of acceleration in the early systolic phase, namely
in the initial part of the curve, which is more uniform; to do
so, we introduced as a new index the maximal systolic
acceleration (ACCmax) (see Materials and Methods and
Figure 1). In addition, as even in normal kidneys the
acceleration drops, going from the proximal to the distal
vessels, we attempted to generate comparable measures
independently from the different levels of the vascular tree
where the Doppler spectra are sampled, introducing another
new index, that is, the maximal acceleration index (AImax), in
order to correct the acceleration for the absolute flow
regimen.
RESULTS
Angiographic and clinical data
According to the instructions described below, the correct
measurements of the conventional and new velocimetric
indices were made in a total of 106 patients (12 with a single
kidney) for a total of 200 kidneys.
On angiography, 57 of these 106 patients were found to
have a RAS; of these, 15 had a bilateral lesion and 42 a
unilateral RAS (in 10 cases, in a solitary kidney) for a total of
72 RAS. In the remaining 49 patients (two with a single
kidney), no RAS was observed on angiography; thus,
including the contralateral non-stenotic kidneys, a total of
128 normal kidneys were examined. The degree, site, and
type of the RAS are illustrated in Figure 2. In 56 out of the 72
RAS the arterial narrowing wasX60%, whereas in five it was
less than 50%, and in the remaining 11 it was between 50 and
59%; thus, in our population, the pre-test probability for a
significant RAS was 28%. The majority of RAS were
atherosclerotic and located at the ostium of the artery,
whereas the fibromuscular ones were mostly located in the
trunk of the renal artery but without any difference in terms
of stenosis significance distribution.
The demographic and most relevant clinical data of
patients with and without angiographically proven RAS are
reported in Table 1. The only significant difference between
these two subgroups was in serum creatinine because of the
inclusion among the patients with RAS of those with bilateral
stenosis.
Echo-Doppler velocimetric data
All velocimetric indices were significantly different in renal
arteries with RAS with respect to the group including arteries
without RAS and with less than 60% RAS (Table 2).
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Figure 1 | (a) Analysis of the Doppler spectra. From this, the
following hemodynamic parameters can be derived: PSV, EDV, the
averaged mean velocity (Vmean) AT taken as the time from the
beginning to the peak of the systole; DVsys indicates the velocity
gradient between the foot and the peak of the systolic phase. From
these parameters, the conventional distal Doppler velocimetric
indices, that is, PI, RI, and the mean acceleration ACCsys, are
calculated as reported in the text. (b) Heterogeneous velocity cycle
slope morphologies that can be found in normal and stenotic renal
arteries. The type ‘A’ morphology has a constant systolic acceleration
until the systolic peak and it is characteristic of a normal
hemodynamic pattern. However, in normal and stenotic arteries
also the ‘B1’ and ‘B2’ morphologies can be found, characterized
respectively by a double peak during the systolic acceleration and
by a shoulder that divides the early steeper acceleration from the
late, less steep phase. The type ‘C’ morphology is characterized by
a flattered cycle with a rounded systolic shape and is typical of
a post-stenotic flow regimen. (c) Illustration of how the cycle
morphologies can affect the calculation of velocimetric indices. It is
obvious that in normal arteries both B type morphologies can cause
a delayed AT resulting in dampened ACCsys, mimicking a condition
similar to that found in stenotic arteries (type C morphology).
(d) Illustration of how the new indices proposed in this study can
improve the diagnostic accuracy in arteries with type ‘B’ morphology.
Focusing on the estimation of the acceleration in the early
systolic phase, we derived the maximal systolic acceleration
(ACCmax¼DVmax/ATmax) defined as the mean slope of the systolic
acceleration until any significant change of its first derivative has
been introduced (white arrow). Moreover, by correcting the
acceleration for the relative absolute velocity regimen, which may
differ at different levels of the renal vascular tree, we derived the
maximal acceleration index (AImax¼ACCmax/PSV).
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However, as illustrated in Figure 3, for both PI and RI, there
was a large overlapping between values observed in the three
subgroups of arteries, leading to a rate of false positive and
negative examinations, which was about 50% for the cutoff of
1.00 and 0.60, respectively.
The diagnostic accuracy of ACCsys, AT, ACCmax, and AImax
for the best thresholds reported in Table 3 was clearly better
than that of PI and RI. Indeed, because of the high sensitivity,
the negative predictive values (NPV) of all these indices were
always X95%. For ACCsys and AT, the rate of false positives
was 44 and 35%, respectively, as illustrated in the upper
panels of Figure 4, which report the percent distribution of
these indices in non-stenotic arteries. The cause of this still
high false positive rate is made apparent in the upper panels
of Figure 5, where non-stenotic arteries with type B cycle
morphology contributed significantly to generate abnormal
values, leading to a false diagnosis of RAS. ACCmax and
AImax, being less biased by the morphology of the velocity
curve waveform and correcting for the angle beam
estimation, at the best cutoff values of 4.0 m/s2 and 9.0 s1
further reduced the false positive rate to 25 and 16%,
respectively (Figures 4 and 5, lower panels). As a result,
the positive predictive values (PPV) of ACCmax and AImax
were 60 and 70%, respectively, that is, higher than those
of ACCsys and AT (45 and 51%, respectively). In addition,
AImax was not affected by the scan site, whereas all the other
indices of acceleration were significantly lower when sampled
in the interlobar arteries with respect to the pre-hilar tract
of the renal artery (Figure 6). Moreover, AImax was not
affected by the etiology and by the location of RAS (analysis
of variance F-value¼ 0.33 and 3.21, Pp0.57 and 0.08,
respectively). However, no significant correlation was found
between AImax or any of the other indices and the degree of
the stenosis.
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Figure 2 | Distribution of the 72 stenotic kidneys with respect to the site, type, and severity of RAS. As expected, there was a prevalence
of fibromuscular RAS in the renal artery trunk in comparison with atherosclerotic RAS, which was more frequently located at the ostium;
between the two types of RAS, there were no significant differences in the severity of the stenosis.
Table 1 | Clinical and laboratory data of patients who were
included in the database for the calculation of echo-Doppler
velocimetric indices (mean7s.d.)
Without RAS
n=49
RAS of any
degree n=57 Po
Age (years) 55713 57716 NS
Gender 14F/35M 22F/35M NS
SBP (mmHg) 165723 168725 NS
DBP (mmHg) 99714 98716 NS
HR (beats/min) 74712 75714 NS
Serum creatinine (mg/dl) 1.070.5 1.570.8 0.01
Serum K+ (mEq/l) 4.370.4 4.370.5 NS
Serum glucose (mg/dl) 100718 94724 NS
Total cholesterol (mg/dl) 219744 222738 NS
DBP: diastolic blood pressure; F: female; HR: heart rare; M: male; NS: not significant;
RAS: renal artery stenosis; SBP: systolic blood pressure.
Table 2 | Velocimetric indices in renal arteries with and
without significant RAS
Significant
stenosis ANOVA
Without significant
stenosis
PI 0.9870.50 Po0.02 1.1270.33
RI 0.5770.012 Po0.01 0.6370.09
AT (ms) 152768 Po0.0001 79749
ACCsys (m/s
2) 1.8071.52 Po0.0001 5.7673.96
ACCmax (m/s
2) 2.2571.78 Po0.0001 7.0973.68
AImax (s
1) 6.0073.22 Po0.0001 14.0374.96
ANOVA: analysis of variance; PI: pulsatility index; RI: resistive index; AT: acceleration
time; ACCsys: mean systolic acceleration; ACCmax: maximal systolic acceleration;
AImax: maximal acceleration index.
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The sensitivity and specificity of AImax at the best cutoff
value of 9.0 s1 were also calculated for the 67 arteries with a
greater than 50% stenosis, and stratified according to the
degree of RAS. These were found to be respectively 88 and
89% for the stenosis X50%, 93 and 84% for those X60 and
92, and 82% for those X70%; the respective PPV and NPV
were 80 and 94%, 70 and 97%, and 64 and 97%.
DISCUSSION
Since the introduction of ultrasonography into the field of
hypertension, several velocimetric indices have been exam-
ined in the search for a reliable first-line screening test of
RAS. Several scientific reports ranged from very poor to
exciting results,5–10 but, so far, it is still unclear which indices
have the best accuracy and where, along the renal circulation,
they should be measured.20–23 Some recent studies9,10 have
shown that the diagnostic accuracy achievable with the
proximal indices is substantially better than that obtained in
earlier investigations; yet, the so-called distal indices appear
preferable to the proximal ones, mostly because the
interrogation of the renal vessels at the parenchymal site
reduces the technical difficulties inherent in the ultrasound
method, making the examination feasible in almost all
patients and relatively less time consuming.12,24,25 Among the
distal indices, we previously found that ACCsys and AT were
clearly superior to PI and RI in detecting both atherosclerotic
and fibromuscular RAS, with an overall diagnostic accuracy
of 85%, but these results were obtained in selected
population of hypertensive patients with a very high
prevalence of RAS.15
The multicentric study of the Italian Group for Reno-
vascular Hypertension offered us the opportunity of extend-
ing that previous observation in a larger population of
hypertensives and of refining the evaluation of the distal
velocimetric indices in order to further improve their ability
to detect a significant RAS.
In agreement with our earlier study, we found that for PI
and RI, the overlap of values observed in kidneys with and
without RAS was clearly greater than that of ACCsys and AT.
The most likely reason for this discrepancy is that the
alterations of ACCsys and AT induced by RAS are less affected
than those of PI and RI by the concomitant impairment of
renal parenchymal blood flow. Indeed, as the latter indices
express a ratio between the maximal and minimal velocities
across the arterial narrowing, the high intrarenal resistance
may counterbalance the pressure gradient induced by RAS,
whereas ACCsys and AT are solely dependent on the maximal
velocity of flow and on the time to peak systolic velocity as
determined by the delayed pulse wave transfer across the
stenosis and/or by the post-stenotic paradoxical increase of
the arterial compliance.19,26 This interpretation is supported
by the notion that in normal arteries, values of PI and RI are
correlated to the renal vascular resistance27 and to the age of
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Figure 3 | Scatter distribution of the pulsatility and resistive
indices (PI and RI) and their mean (7s.d.) values sampled
in parenchymal arteries in kidneys without RAS and with
significant and not significant RAS. A large overlapping
between the three subgroups of arteries is evident.
Table 3 | Sensitivity, specificity, PPV, and NPV of the four
acceleration-derived indices calculated for the ideal cutoff
limits established with the ROC curve
AT ACCsys ACCmax AImax
Best cutoff 80 ms 4.0 m/s2 4.0 m/s2 9.0 s1
Sensitivity (%) 93 93 94 93
Specificity (%) 65 56 75 84
PPV (%) 51 45 60 70
NPV (%) 96 95 97 97
ROC curve: receiver operating characteristic curve; PPV: positive predictive value;
NPV: negative predictive value; for other abbreviations, see Table 2 footnote.
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Figure 4 | Histogram distribution of ACCsys, AT, ACCmax, and AImax
in the 144 renal arteries with no RAS (n¼ 128) and with not
significant RAS (n¼ 16). The gray area includes the false positive
studies, which are clearly reduced with ACCmax and even more so
with AImax (abbreviations are as in the text).
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patients,28 whereas no such correlation was found for ACCsys
and AT.15 Moreover, we have previously shown that in
kidneys with atherosclerotic RAS, the alterations in PI and RI
were less pronounced than those in ACCsys and AT, whereas
this did not occur in younger patients with fibromuscular
RAS, indicating that PI and RI also have the disadvantage of
being affected by the etiology of stenosis.15 Thus, the practical
conclusion that can be drawn from the more extensive
findings of the present study is that the diagnostic accuracy of
PI and RI is unacceptably low for a screening test of RAS,
although these indices maintain their validity for estimating
the district vascular impedance in non-stenotic kidneys27,29
or in stenotic kidneys for evaluating the degree of nephro-
sclerosis, as a prognostic sign of poor clinical outcome after
angioplasty.30
However, not even ACCsys and AT are entirely satisfactory
in that, in spite of their excellent NPV, we found in non-
stenotic kidneys a heterogeneous distribution of Doppler
cycle morphologies, with a substantial percent of type B
curves mimicking the ‘pulsus tardus’ pattern typical of the
stenotic ones; as a consequence, values of AT had a bimodal
distribution, which explains the false positives observed even
with this index. The same limitations apply to ACCsys, whose
values are additionally affected by the flow regimen at the
scan site and by the scan angle.
Results of this study provide evidence that by focusing on
the evaluation of acceleration in the early systolic phase,
namely in the initial part of the curve, which is more
uniform, by calculating the ACCmax, most of the biasing
factors due to the cycle morphology can be circumvented.
Further correction for the flow regimen, as stated by the peak
systolic velocity, resulting in the calculation of AImax can also
overcome the bias due to different scan site or wrong angle
beam correction. Indeed, for the ideal cutoff values, the PPV
of ACCmax and AImax rose to 60 and 70%, respectively,
maintaining an NPV of 97% for both. It is of interest that the
sensitivity, specificity, PPV and NPV of AImax were essentially
similar for all RAS above 50%, thus making this index useful
for detecting even relatively mild narrowing of the renal
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parenchymal arteries. The dotted line represents the ideal cutoff values calculated for each index with the ROC curve analysis, whereas the
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arteries. These PPV are nevertheless lower than those found
for AT (91%) in the study of Burdick et al.,15 but it must be
appreciated that the predictive values are highly dependent
on the prevalence of the disease in the population under
investigation and that in that study the pre-test probability of
RAS was 75%, whereas in this study it was remarkably lower
(28%). Also, at variance with Burdick’s study, no correlation
was found between AT and any of the new indices and the
degree of arterial narrowing. One possible explanation is
that, in this study, the proportion of patients with an
atherosclerotic RAS, in whom this correlation was found to
be much weaker than that in fibromuscular RAS, was 78
against 57%.
The results of the present study are very similar to those of
Johansson et al.16 whose Doppler measurements reached an
NPV and PPV of 97 and 71%, respectively, in a population of
hypertensive patients with a prevalence of RAS of 19%;
however, in their study, such a high NPV was obtained by
combining the measurement of acceleration with that of the
side-to-side difference of PI. Moreover, in their protocol, the
Doppler evaluations were made in the interlobar renal
arteries where the systolic acceleration is obviously lower
than that in the main or segmental renal artery. Thus, the
ideal cutoff values proposed by these investigators are
applicable only to a specific site of the renal arterial tree;
this limitation does not apply to AImax, the values of which
are already adjusted for the different sites of interrogation of
the velocity spectra (see Figure 6).
One limitation of this investigation is that because of the
study design, no comparative analyses of the new indices and
of the proximal ones were performed; thus, it cannot be
established from the present data which of the two
approaches is superior. However, future studies exploiting
the advantages of ACCmax and AImax might explore to what
extent their evaluation in combination with that of the
proximal indices can further improve the accuracy of
ultrasound examination in detecting a significant RAS.
A final consideration pertains to the applicability of these
new indices to the ‘real life conditions’ in which these
ultrasonographic investigations are usually performed. The
time required to perform such detailed interrogations of
renal arteries was 32 min, and this may be the limiting factor
in the daily schedule of a busy ultrasonographer; yet, it is
worth recalling that limiting the investigation to parenchymal
vessels and restricting the calculation just to the two new
indices may reduce the time required for each procedure, on
average, to less than 15 min.
In conclusion, in a cohort of hypertensive patients with a
28% prevalence of greater than 60% RAS, PI and RI had an
NPV too low to make these indices useful as a screening test.
In contrast, all the four acceleration indices we tested had a
very high NPV but only AImax had a sufficiently high PPV.
Thus, AImax, owing to its ability to overcome the factors
biasing the Doppler evaluation, appears superior to the other
distal indices and promising as a screening test in patients
with the clinical suspicion of RAS.
MATERIALS AND METHODS
Patients and protocol
This study is a subproject of a larger prospective study on the
prevalence, diagnosis, and treatment of renovascular hypertension
undertaken by the Italian Group for the Study of Renovascular
Hypertension under the auspices and the direction of the Italian
Society of Hypertension. Nineteen Italian Hypertension Units
participating in the study recruited a total of 459 hypertensive patients
who were admitted to the hospital for the strong clinical suspicion of
renovascular hypertension, as indicated in detail elsewhere.31
In short, patients of both genders and without limitation of age
and of concomitant conditions except advanced cancer and
pregnancy were admitted to the study. Whenever it was ethically
possible, 2 weeks before admission and during the study period
patients underwent a wash-out of the antihypertensive treatment
they were on; when this was not feasible, care was taken to use
calcium channel blockers and alpha-blockers to control blood
pressure, unless the abstinence from other medications was
considered clinically dangerous.
The protocol included a daily blood pressure monitoring, the
collection of peripheral blood sample for the evaluation of a
complete biochemical profile, a urine analysis, and the evaluation of
target organ damage estimated with an EKG and with a cardiac
echo-Doppler. In addition, patients underwent numerous investi-
gations aimed at detecting the presence of RAS; these included the
determination of plasma renin activity and plasma aldosterone, a
renal scintigraphy, a computed axial tomography and a three-
dimensional magnetic resonance and an echo-Doppler velocimetry
of renal arteries. Each procedure was performed by an independent
operator who was unaware of the outcome of the others.
In order to standardize the results obtained by different
operators, all centers received detailed instructions on how to
perform the various procedures, which were executed depending on
the facilities available in each center and according to the sequence
selected by the physician in charge. However, as a final investigation
and independently from the results of the previous ones, all patients
underwent a conventional renal angiography or aortography, the
results of which were taken as reference for confirming or denying
the presence of RAS.
The angiography was performed taking at least two views of all
arteriograms to assess the severity of RAS. The degree of the arterial
narrowing was estimated visually by the responsible radiologist of
each center. In the light of the known discrepancies in RAS reports
among different observers,32 all involved radiologists were instructed
to classify the RAS as atherosclerotic or fibromuscular and,
according to its localization, as ostial/paraostial, median, or distal.
The severity of RAS was estimated comparing the caliber of the
vessel at its narrowest point to that distal to the stenosis just before
the bifurcation, and the degree of narrowing was categorized as
below 50%, 50–59, 60–69, 70–79, 80–89, and 90% or more. Owing to
the known difficulties in evaluating the RAS of the polar renal
arteries, the radiologist’s reports were confined to the description of
the main renal arteries.33 On the basis of some recent ultrasono-
graphic studies,9,34,35 a narrowing of the renal artery equal or greater
than 60% was taken as a cutoff value to define a RAS as
hemodynamically significant.
Echo-Doppler technique
All participating centers received detailed instructions in order to
standardize this procedure (see below). As this study was designed to
prospectively mirror the routine investigation of this kind of
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patients, each center was left free to perform the echo investigation
according to the skill of the local physician/ultrasonographer and
the available facilities. Thus, only in six centers, it has been possible
to measure the early systolic acceleration phase, the cycle type, and
the calculation of ACCmax and the relative AImax as indicated below.
All patients were investigated in a blind manner with respect to
the other diagnostic procedures including angiography and,
whenever possible, at the end of the pharmacological wash-out
period. Patients were investigated in the morning in the fasting state
after at least 30 min in a recumbent position, with scan window in a
semilateral position at the subcostal or lateral projection. The
coronal or longitudinal scan of the kidney was adjusted with
minimal depth to emphasize the view of the parenchymal vessels
and to allow a scan angle with respect to the artery below 451 as
guided on the basis of the color-Doppler encoding. The PW-
Doppler spectral signal was captured from the parenchymal arteries,
with the best signal magnification more distal to the pre-hilar artery
until the interlobaris, the latter within the intramedullary portion,
however far from the flow dividers. The average time needed for
carrying out a full investigation at the pre-hilar renal artery and
parenchymal sites was 32713 min, whereas the investigation limited
at the parenchymal arteries required 1476 min.
Calculation of Doppler velocimetric indices
PI, RI, ACCsys, and AT were derived from the analysis of the Doppler
spectra and calculated as follows:
PI ¼ ðPSVEDVÞVmean ; RI ¼
ðPSVEDVÞ
PSV ; ACCsys ¼
DVsys
AT
where PSV, EDV, and Vmean are the peak systolic, end diastolic, and
cycle average velocities, respectively, and DVsys and AT (ms) are the
velocity gradient and time delay from the beginning to the peak of
the systolic phase, respectively (Figure 1a). However, in comparison
with a typical normal cycle, characterized by a relatively constant
acceleration and an early systolic peak, there are spectra still
belonging to the normal hemodynamic pattern, in which the
acceleration phase has a double peak or a shoulder that divides the
early steeper acceleration from the late less steep phase resulting in
slowed systole (Figure 1b).19 As a result, if the latter waveform
patterns are sampled from normal renal arteries, an overestimation
of AT and an underestimation of ACCsys may occur and lead to a
false diagnosis of RAS (Figure 1c). The new index ACCmax (m/s
2)
was defined as the mean slope of the systolic acceleration until any
significant change of its first derivative in the second half of the
acceleration, that is, at the point of the acceleration curve where a
slope change is clearly evident (Figure 1d), whereas the maximal
acceleration index (AImax, s
1), that is, the maximal slope of the
systolic acceleration corrected for the relative district flow regimen
(as stated by PSV), was calculated as follows:
AImax ¼ ACCmaxðm=s
2Þ
PSVðm=sÞ
Statistical analysis
Site distribution, etiology, and degree of RAS were compared by w2
analysis. The clusters of each parameter divided on the basis of
degree, type, or site of the stenosis were compared by analysis of
variance.
According to the aim of the study, based on the evaluation of
echo-Doppler velocimetry as a screening test for significant RAS, the
sensitivity, specificity as well as the PPV and NPV were calculated for
each index; moreover, the ideal cutoff limit was established with the
ROC (receiver operating characteristic) curve technique.
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Appendix 1
Responsible investigators and centers participating in the
Italian Group for the Study of Renovascular Hypertension: A
Morganti (Milano-Policlinico) (principal investigator and
study coordinator), P Dessı`-Fulgheri (Ancona), V Vulpis
(Bari), E Strocchi (Bologna), M Beschi (Brescia), L Malatino,
I Bellanuova (Catania), R Quartagno (Milano-San Raffaele),
S Carugo (Monza), F Pasanisi (Napoli), G Rossi (Padova), S
Cottone (Palermo), E Fommei (Pisa-Fisiologia Clinica), S
Pinto (Pisa-Istituto Clinica Medica), P Finocchiaro (Reggio
Calabria), S Mazzaferro (Roma), Franco Veglio, Mauro
Frascisco (Torino), M Bardelli, R Carretta (Trieste), E Arosio,
S De Marchi (Valeggio), E Valvo (Verona).
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